View Item 

Show simple item record

Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia

dc.contributor.authorThornburg, C. D.en_US
dc.contributor.authorPipe, Steven W.en_US
dc.date.accessioned2010-06-01T21:13:07Z
dc.date.available2010-06-01T21:13:07Z
dc.date.issued2006-03en_US
dc.identifier.citationTHORNBURG, C. D.; PIPE, S. W. (2006). "Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia." Haemophilia 12(2): 198-199. <http://hdl.handle.net/2027.42/74297>en_US
dc.identifier.issn1351-8216en_US
dc.identifier.issn1365-2516en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74297
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16476098&dopt=citationen_US
dc.format.extent56471 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 Blackwell Publishing Ltden_US
dc.titleAdherence to prophylactic infusions of factor VIII or factor IX for haemophiliaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid16476098en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74297/1/j.1365-2516.2006.01172.x.pdf
dc.identifier.doi10.1111/j.1365-2516.2006.01172.xen_US
dc.identifier.sourceHaemophiliaen_US
dc.identifier.citedreferenceBerntorp E, Boulyjenkov V, Brettler D et al. Modern treatment of haemophilia. Bull World Health Organ 1995; 73: 691 – 701.en_US
dc.identifier.citedreference2 Medical and Scientific Advisory Council. MASAC Recommendations Concerning Prophylaxis Medical Bulletin no. 193 (Chapter Advisory 197). 1994.en_US
dc.identifier.citedreferenceShapiro AD. Why is primary prophylaxis underutilized in the United States ? Haemophilia 2003; 9: 670 – 2.en_US
dc.identifier.citedreferenceBlanchette VS, McCready M, Achonu C, Abdolell M, Rivard G, Manco-Johnson MJ. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres. Haemophilia 2003; 9 ( Suppl. 1 ): 19 – 26.en_US
dc.identifier.citedreferenceSchramm W, Berger K. Economics of prophylactic treatment. Haemophilia 2003; 9 ( Suppl. 1 ): 111 – 5.en_US
dc.identifier.citedreferenceHacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7: 392 – 6.en_US
dc.identifier.citedreferenceBecker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH, Taylor DW. Patient perceptions and compliance: recent studies of the health belief model. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: The Johns Hopkins University Press, 1979: 78 – 109.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2516.2006.01172.x.pdf
Size:
55.14KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.